Have questions about Haute MD?

    Schedule a quick call with our membership team. No obligation.

    Full refund if not approved · Benefits activate day one

    hair-loss

    Alopecia Areata: What It Is and How It's Treated

    Last reviewed: May 2026 · Haute MD Editorial Team

    Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, causing sudden, patchy hair loss — typically in round or oval patches on the scalp, though it can affect eyebrows, eyelashes, and body hair. It affects approximately 2% of the population at some point in their lifetime. Unlike genetic hair loss, alopecia areata does not destroy the follicle — regrowth is possible, and in many cases hair returns spontaneously. Treatment aims to suppress the immune response and stimulate regrowth.

    Types of alopecia areata

    Patchy alopecia areata involves one or more localized patches of hair loss — the most common form and the most likely to spontaneously resolve. Alopecia totalis involves complete loss of all scalp hair. Alopecia universalis involves complete loss of all body hair including eyebrows and eyelashes. Ophiasis pattern affects the lower and lateral scalp in a band pattern and is more treatment-resistant. Diffuse alopecia areata causes overall thinning across the scalp rather than distinct patches.

    Treatment options

    Corticosteroid injections (intralesional triamcinolone) are the first-line treatment for patchy alopecia areata — injected directly into the patch every 4-6 weeks. Topical corticosteroids and minoxidil can support regrowth. Contact immunotherapy (topical DPCP or SADBE) is used for extensive patchy disease. JAK inhibitors — baricitinib (Olumiant) and ritlecitinib (Litfulo) — are now FDA-approved specifically for severe alopecia areata, representing the first systemic treatments specifically approved for this condition.

    The role of stress and triggers

    Alopecia areata has a complex relationship with stress. Physical stress (illness, surgery) and emotional stress can trigger or worsen flares in people with a genetic predisposition. However, alopecia areata is an autoimmune condition — not caused by stress alone. Managing stress through evidence-based approaches (exercise, sleep, therapy) supports overall health but does not reliably prevent or reverse alopecia areata flares.

    Frequently Asked Questions

    Will my alopecia areata hair grow back?

    In many cases, yes. Approximately 80% of people with limited patchy alopecia areata see spontaneous regrowth within one year, though recurrence is common. More extensive forms (totalis, universalis) have lower spontaneous regrowth rates. The follicle is not destroyed in alopecia areata, so regrowth potential is preserved.

    What are JAK inhibitors for alopecia areata?

    JAK inhibitors are a class of targeted oral immunosuppressants. Baricitinib (Olumiant) and ritlecitinib (Litfulo) are FDA-approved for severe alopecia areata. Clinical trials showed significant regrowth in patients with long-standing severe disease. They require monitoring for immune suppression-related side effects.

    Is alopecia areata contagious?

    No. Alopecia areata is an autoimmune condition — the immune system attacking the body's own hair follicles. It is not contagious and cannot be transmitted by contact.

    Does alopecia areata affect hair permanently?

    In most cases, the follicle is preserved even during active loss — it is "silenced" by the immune attack but not destroyed. This means regrowth is possible even after years of hair loss. Only in very long-standing cases does the follicle begin to lose regrowth potential.

    Get Help Now

    Speak with a Haute MD Dermatology physician

    Are you a Dermatology physician?

    Join Haute MD Network and have your profile featured alongside these answers.

    Apply for the Network

    Related Guides

    Are you a hair-loss physician?

    Join Haute MD Network and have your profile featured alongside these answers — published on HauteLiving.com, a verified Google News publisher since 2005.

    Apply for the Network